April 7, 2021
April 7, 2021 —
After successfully preventing outbreaks of COVID-19 through its nationally recognized Return to Learn program, the University of California San Diego has announced plans to have a campus nearly fully occupied for fall 2021.
April 2, 2021
April 2, 2021 —
UC San Diego researchers found that the chemical inhibitor K777 reduces the coronavirus’ ability to infect cell lines by blocking human enzyme cathepsin L; clinical trials are underway.
April 1, 2021
April 1, 2021 —
UC San Diego students will participate in nationwide clinical trial to assess if COVID-19 vaccination prevents infection and reduces risk of transmission.
March 23, 2021
March 23, 2021 —
Investigators from UC San Diego and UCLA report COVID-19 infection rates for a cohort of health care workers previously vaccinated for the novel coronavirus. Risk of infection is minuscule, but exists.
March 18, 2021
March 18, 2021 —
Using molecular dating tools and epidemiological simulations, researchers at UC San Diego School of Medicine estimate that the SARS-CoV-2 virus likely circulated undetected for two months before the first human cases of COVID-19 were described in Wuhan, China in late-December 2019.
March 5, 2021
March 5, 2021 —
Researchers have shown that three-layered surgical masks are more effective than single or double-layered masks at stopping large droplets from a cough or sneeze from getting atomized into smaller droplets and penetrating through the mask.
March 4, 2021
March 4, 2021 —
Exercise has long-been recommended as a cognitive-behavioral therapy for patients of depression, yet new evidence from the University of California of San Diego suggests that the COVID-19 pandemic changed the nature of the relationship between physical activity and mental health.
March 3, 2021
March 3, 2021 —
UC San Diego School of Medicine researchers develop an automated process to test city sewage for SARS-CoV-2, allowing them to forecast the region’s COVID-19 caseload one to two weeks ahead of clinical diagnostic reports.
March 2, 2021
March 2, 2021 —
Rapid COVID-19 tests are on the rise to deliver results faster to more people, and scientists need an easy, foolproof way to know that these tests work correctly and the results can be trusted. Nanoparticles that pass detection as the novel coronavirus could be just the ticket.
March 1, 2021
March 1, 2021 —
A repurposed drug used to treat arthritis did not significantly improve the outcomes of patients with severe COVID-19 pneumonia. Tocilizumab did not significantly improve clinical status or mortality rate at 28 days for participants who received it compared to a placebo.
